Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,777 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of CD4+-guided pentostatin lymphodepletion and pharmacokinetically targeted busulfan as conditioning for hematopoietic cell allografting.
Kharfan-Dabaja MA, Anasetti C, Fernandez HF, Perkins J, Ochoa-Bayona JL, Pidala J, Perez LE, Ayala E, Field T, Alsina M, Nishihori T, Locke F, Pinilla-Ibarz J, Tomblyn M. Kharfan-Dabaja MA, et al. Among authors: perkins j. Biol Blood Marrow Transplant. 2013 Jul;19(7):1087-93. doi: 10.1016/j.bbmt.2013.04.020. Epub 2013 Apr 28. Biol Blood Marrow Transplant. 2013. PMID: 23632090 Free PMC article. Clinical Trial.
Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery.
Ballester OF, Agaliotis DP, Hiemenz JW, Janssen WE, Fields KK, Zorksy PE, Goldstein SC, Perkins JB, Elfenbein GJ. Ballester OF, et al. Among authors: perkins jb. Bone Marrow Transplant. 1996 Jul;18(1):9-14. Bone Marrow Transplant. 1996. PMID: 8831989 Clinical Trial.
High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency.
Ballester OF, Tummala R, Janssen WE, Fields KK, Hiemenz JW, Goldstein SC, Perkins JB, Sullivan DM, Rosen R, Sackstein R, Zorsky P, Saez R, Elfenbein GJ. Ballester OF, et al. Among authors: perkins jb. Bone Marrow Transplant. 1997 Oct;20(8):653-6. doi: 10.1038/sj.bmt.1700950. Bone Marrow Transplant. 1997. PMID: 9383228 Clinical Trial.
Are matched unrelated donor transplants justified for AML in CR1?
Anasetti C, Perkins J, Nieder ML, Field T. Anasetti C, et al. Among authors: perkins j. Best Pract Res Clin Haematol. 2006;19(2):321-8. doi: 10.1016/j.beha.2005.12.002. Best Pract Res Clin Haematol. 2006. PMID: 16516129 Review.
5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation.
Field T, Perkins J, Huang Y, Kharfan-Dabaja MA, Alsina M, Ayala E, Fernandez HF, Janssen W, Lancet J, Perez L, Sullivan D, List A, Anasetti C. Field T, et al. Among authors: perkins j. Bone Marrow Transplant. 2010 Feb;45(2):255-60. doi: 10.1038/bmt.2009.134. Epub 2009 Jun 22. Bone Marrow Transplant. 2010. PMID: 19543327
Infliximab for managing steroid-refractory acute graft-versus-host disease.
Pidala J, Kim J, Field T, McBride A, Kharfan-Dabaja M, Perkins J, Fernandez H, Perez L, Ayala E, Anasetti C. Pidala J, et al. Among authors: perkins j. Biol Blood Marrow Transplant. 2009 Sep;15(9):1116-21. doi: 10.1016/j.bbmt.2009.05.019. Biol Blood Marrow Transplant. 2009. PMID: 19660725 Free article.
1,777 results